Medsir

This study is testing a drug called Trastuzumab-Deruxtecan (T-DXd) for people with a specific type of advanced breast cancer (HER2-low) that has spread to the brain. The main goal is to see how well the drug shrinks these brain tumors. It will also track side effects and how the …

This study is testing a new drug, MEN1611, given alone and with a chemotherapy called eribulin, for people with advanced breast cancer that has specific genetic changes. The goal is to see if these treatments can help control the cancer and are safe. It is for patients whose canc…

This study is testing an experimental drug called HER3-DXd for patients whose cancer has spread to the brain or the lining of the spinal cord. It is for adults with advanced breast cancer, non-small cell lung cancer, or other solid tumors who have already tried at least one other…

This study is testing whether adding a new oral drug, Debio 0123, to an existing cancer drug, sacituzumab govitecan, is safe and can help control advanced breast cancer. It is for people whose cancer has worsened after one or two prior treatments. The goal is to see if this combi…

This study tests whether a combination of three drugs (pembrolizumab, carboplatin, and paclitaxel) given before surgery can completely eliminate cancer in patients with early-stage triple-negative breast cancer. The trial involves 30 participants who haven't had previous cancer t…

This study is testing whether some patients with early-stage, HER2-positive breast cancer can be successfully treated without chemotherapy. It uses a combination of targeted antibody drugs given as an injection under the skin. The treatment plan is adjusted after surgery based on…